WinSanTor Revenue and Competitors
Estimated Revenue & Valuation
- WinSanTor's estimated annual revenue is currently $3.3M per year.
- WinSanTor's estimated revenue per employee is $155,000
Employee Data
- WinSanTor has 21 Employees.
- WinSanTor grew their employee count by -12% last year.
WinSanTor's People
| Name | Title | Email/Phone |
|---|
WinSanTor Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is WinSanTor?
WinSanTor Inc. is a clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo-induced peripheral neuropathy, HIV-induced and others. WinSanTor was founded by scientists and industry experts who share the vision that recent scientific insights into the biological processes underlying degenerative diseases offer an unprecedented opportunity to discover and develop effective medicines. WinSanTor is rigorously pursuing a science-driven approach to translational medicine and clinical development.
keywords:N/A
N/A
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.1M | 21 | -9% | N/A |
#2 | $4M | 21 | -5% | N/A |
#3 | $2.1M | 21 | N/A | N/A |
#4 | $1.1M | 21 | N/A | N/A |
#5 | $3.3M | 21 | -12% | N/A |